Japan Vietnam Medical Investment and Development JSC (HOSE:JVC)

Vietnam · Delayed Price · Currency is VND

2,940.00

-10.00 (-0.34%)

At close: Aug 28, 2026

HOSE:JVC Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Revenue	747,221	763,153	611,540	576,287	499,432	507,338
Revenue Growth	14.41%	24.79%	6.12%	15.39%	-1.56%	-43.20%
Gross Profit	165,277	148,917	147,572	138,863	93,981	3,386
Operating Income	63,037	52,796	36,510	27,308	-26,745	-1,192,003
Net Income	50,780	49,945	40,282	52,634	-31,694	-1,335,782
Earnings Per Share	451.38	443.96	358.00	467.86	-281.73	-11873.60
EPS Growth	-2.81%	24.01%	-23.48%	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025
Providing Services	59,619	50,691
Medical Device Integration Activities	29,097	67,729
Sale of Medical Machinery and Equipment	674,437	493,120
Total	763,153	611,540

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Cash & Investments	146,949	29,228	19,582	153,516	37,500	16,557
Total Debt	225,198	303,082	140,829	92,726	35,721	51,611
Net Cash (Debt)	-78,249	-273,854	-121,247	60,790	1,778	-35,054
Net Cash Growth	-	-	-	3318.23%	-	-
Net Cash Per Share	-695.55	-2434.25	-1077.75	540.36	15.81	-311.59

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Operating Cash Flow	259,699	-88,546	85,753	-6,474	76,126	-319,023
Capital Expenditures	-20,451	-41,862	-16,594	-43,363	-42,587	-8,810
Free Cash Flow	239,248	-130,408	69,159	-49,837	33,540	-327,834
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Gross Margin	22.12%	19.51%	24.13%	24.10%	18.82%	0.67%
Operating Margin	8.44%	6.92%	5.97%	4.74%	-5.36%	-234.95%
Pretax Margin	8.38%	8.05%	9.63%	9.70%	-5.94%	-263.34%
Profit Margin	6.80%	6.54%	6.59%	9.13%	-6.35%	-263.29%
FCF Margin	32.02%	-17.09%	11.31%	-8.65%	6.72%	-64.62%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
PE Ratio	6.51	13.72	10.61	7.22	-	-
Forward PE	-	9.64	9.64	9.64	9.64	9.64
P/FCF Ratio	1.38	-	6.18	-	11.64	-
PS Ratio	0.44	0.90	0.70	0.66	0.78	1.02